MedPath

Epidemiological Study of Fabry Disease in Taiwan Young Stroke Patients

Conditions
Fabry Disease
Registration Number
NCT03596398
Lead Sponsor
Chiayi Christian Hospital
Brief Summary

Epidemiological Study of Fabry Disease in Taiwan Young Stroke Patients

Detailed Description

This is a cross-sectional, population-based study. No randomization procedure will be executed in this study. Approximately 1000 subjects over a 36-month period. The aim of this screening study is to identify the Fabry disease as the cause in patients with young stroke.

To measure the level of α-Gal A activity, male subjects will initially provide a DBS sample and female subjects will start with a test by whole blood sample.

The prevalence of Fabry disease among patients with young stroke will be estimated by a confirmative diagnosis in gene testing.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Patients aged 20 or over
  • Patients aged under 56 years old, not included 56
  • Patients with acute stroke
  • Patients and/or their legal representatives are willing to provide written informed consent
Exclusion Criteria
  • Patients with a confirmed diagnosis of Fabry disease

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fabry disease3 years later

The prevalence of Fabry disease in patients with young stroke

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.